The treatment of TF-expressing BxPC-3 cells, in vitro or in vivo, using anti-TF antibody conjugated with indocyanine green (ICG), followed by near-infrared photoimmunotherapy (NIR-PIT) of tumor lead to the death of cancer cells (Aung et al., 2018). The gene discussed is TF; the disease is neoplasm.